Dkk-1

Dkk-1 詳細

英語名Dickkopf-related protein 1市販薬剤の数0
治験薬の数4ターゲットの別称Dickkopf-Like Protein 1,Dickkopf 1 Homolog,Dickkopf-1 Like,Dickkopf-1,Dkk-1,UNQ492/PRO1008,Dickkopf-related protein 1,hDkk-1,SK,DKK1,Dickkopf WNT Signaling Pathway Inhibitor 1,Dickkopf 1 Homolog (Xenopus Laevis),Dickkopf (Xenopus Laevis) Homolog 1
研究&開発段階Phase 2 Clinical
英語名Dickkopf-related protein 1
ターゲットの別称Dickkopf-Like Protein 1,Dickkopf 1 Homolog,Dickkopf-1 Like,Dickkopf-1,Dkk-1,UNQ492/PRO1008,Dickkopf-related protein 1,hDkk-1,SK,DKK1,Dickkopf WNT Signaling Pathway Inhibitor 1,Dickkopf 1 Homolog (Xenopus Laevis),Dickkopf (Xenopus Laevis) Homolog 1
市販薬剤の数0
治験薬の数4
研究&開発段階Phase 2 Clinical

Dkk-1 製品リスト

  • 属性

    Protein (4)

  • 製品ライブラリ

    オンライン (4)

  • Human (3)Mouse (1)

  • タグ

    His Tag (2)Fc Tag (1)Fc Tag & Avi Tag (1)

  • マーカー

    Unconjugated (3)Biotin-labeled (1)

製品番号発現システム製品説明タンパク質の構造純度特性
DK1-H5221
Human
HEK293
Human Dkk-1 Protein, His Tag, premium grade
DK1-H5258
Human
HEK293
Human Dkk-1 Protein, Fc Tag (MALS verified)
DK1-H82F5
Human
HEK293
Biotinylated Human Dkk-1 Protein, Fc,Avitag™
DK1-M52H6
Mouse
HEK293
Mouse Dkk-1 Protein, His Tag
総数量4
  • 1

Dkk-1バックグランド

Members of the dickkopf-related protein family (DKK-1, -2, -3, and -4) are secreted proteins with two cysteine-rich domains separated by a linker region. And DKK1 takes part in embryonic development through its inhibition of the WNT signaling pathway, binds to LRP6 with high affinity and prevents the Frizzled-Wnt-LRP6 complex formation in response to Wnts. DKK1 promotes LRP6 internalization and degradation when it forms a ternary complex with the cell surface receptor Kremen.DKK1 not olny functions as a head inducer during development, but also regulates joint remodeling and bone formation, which suggests roles for DKK1 in the pathogenesis of rheumatoid arthritis and multiple myeloma. More recently research reported, DKK1 impacts eye development from a defined developmental time point on, and is critical for lens separation from the surface ectoderm via β-catenin mediated Pdgfrα and E-cadherin expression.

Dkk-1分子の別称

DKK1,SK

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
JS-015JS-015Phase 2 ClinicalShanghai Junshi Biological Engineering Co LtdColorectal Neoplasms; Neoplasms; Solid tumours
詳細
AGA-2115AGA2115; AGA-2115Phase 2 ClinicalAngitia Biopharmaceuticals (Guangzhou) LtdOsteogenesis Imperfecta
詳細
AGA-2118AGA-2118Phase 2 ClinicalAngitia Biomedicines LtdOsteoporosis; Osteoporosis, Postmenopausal
詳細
SirexatamabDKN-01; LY-2812176Phase 2 ClinicalEli Lilly And CompanyBile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinosarcoma; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Liver Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Prostatic Neoplasms; Solid tumours; Stomach Neoplasms; Uterine Neoplasms
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8